Please assess the completion status of the following clinical trial:

Trial Title: Body-image Satisfaction Following Permanent Black or Invisible UV Ink Tattoos

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female age 18-60.~* Histologically confirmed early stage invasive ductal or lobular carcinoma of a single breast (T1N0M0-T2N0M0) or DCIS/LCIS (TisNxMx or TisN0M0) of a single breast.~* Deemed fit to undergo adjuvant radiotherapy to their breast by their supervising radiation oncologist.~* Able to provide written informed consent.~* Must be willing to be contacted by e-mail and have a valid e-mail account to complete follow up self-reported body image scale questionnaires.~* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1.~* Intact skin at site of standard radiotherapy tattoos. Must have access to a computer and be able and willing to comply with requirements of the protocol.~Exclusion Criteria:~* History of any prior radiotherapy courses to the chest or abdomen.~* Metastatic disease.~* Node positive breast cancer.~* Bilateral breast cancer or bilateral DCIS/LCIS.~* Deep-inspiration breath hold radiotherapy technique.~* Unable or unwilling to comply with the requirements of the protocol as assessed by the study investigator or coordinator.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Arm 1 - UV ink (Type: EXPERIMENTAL): Radiotherapy tattoos will be applied using an invisible UV fluorescent ink that can only be detected while illuminated with a special ultraviolet flashlight.
- Arm 2 - Black ink (Type: NO_INTERVENTION): Radiotherapy tattoos will be applied using standard black ink.

Based on this trial design, predict the completion outcome and termination type (if applicable).